Company: IMCR
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001671927-25-000018
Chunk: 48

Company: Immunocore Holdings plc
Filing Date: 2025-11-06
Form: 10-Q
Item: Part II, Item 5
Chunk 48
---
Table of Contents

Item 5. Other Information

Insider Trading Arrangements

During our last fiscal quarter, our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated the contracts, instructions or written plans for the purchase or sale of our securities as set forth in the table below. Type of Trading ArrangementName and PositionActionAdoption/ TerminationDateRule 10b5-1(1)Non-Rule 10b5-1(2)Total Ordinary Shares to be Sold(3)Expiration DateRoy S. Herbst, M.D., Ph.D.Non-Executive DirectorAdoptionSeptember 15, 2025X10,620December 11, 2026(1)     Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.(2)     “Non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K under the Exchange Act. 

(3)     Represents ordinary shares in the form of American Depositary Shares.